Article Text

Download PDFPDF

Management of reflux disease
  1. J Dent
  1. Correspondence to:
    Professor J Dent, Department of Gastrointestinal Medicine, Level 7, North Wing, Royal Adelaide Hospital, North Terrace, Adelaide SA5000, Australia;


The management of reflux disease can be divided into three major phases, the first being diagnosis and severity assessment, the second, prompt initial control of symptoms, and the third, selection of a long term management approach that is tailored to meet individual patient needs and preferences. Throughout these phases of management, the major priorities should include achieving patient satisfaction and minimising management costs.

  • diagnosis
  • reflux disease
  • severity assessment
  • symptom control
  • symptom evaluation
  • H2RA, H2 receptor antagonist
  • PPI, proton pump inhibitor

Statistics from


  • Conflict of interest: This symposium was sponsored by AstraZeneca, makers of omeprazole. The author of this paper has received sponsorship for travel and an honorarium from AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles